Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism
Over 80% of multiple-tested siRNAs and shRNAs targeting CD95 or CD95 ligand (CD95L) induce a form of cell death characterized by simultaneous activation of multiple cell death pathways preferentially killing transformed and cancer stem cells. We now show these si/shRNAs kill cancer cells through can...
Main Authors: | William Putzbach, Quan Q Gao, Monal Patel, Stijn van Dongen, Ashley Haluck-Kangas, Aishe A Sarshad, Elizabeth T Bartom, Kwang-Youn A Kim, Denise M Scholtens, Markus Hafner, Jonathan C Zhao, Andrea E Murmann, Marcus E Peter |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2017-10-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/29702 |
Similar Items
-
CD95/Fas ligand mRNA is toxic to cells
by: Will Putzbach, et al.
Published: (2018-10-01) -
Lentivirus expressing shRNAs inhibit the replication of contagious ecthyma virus by targeting DNA polymerase gene
by: Leila Asadi Samani, et al.
Published: (2020-03-01) -
In vitro Inhibition of Border Disease Virus Replication With Lentivirus-Mediated shRNAs
by: Mohammad Javad Hajihasani Arani, et al.
Published: (2021-08-01) -
Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice
by: Anne Dallas, et al.
Published: (2013-01-01) -
CRISPR/Cas9-Mediated Hitchhike Expression of Functional shRNAs at the Porcine <i>miR-17-92</i> Cluster
by: Chao Lu, et al.
Published: (2019-02-01)